Search Results - Conway, Jake

UpSetR: an R package for the visualization of intersecting sets and their properties by Conway, Jake R, Lex, Alexander, Gehlenborg, Nils

Get full text Get full text Get full text

Next-Generation Sequencing and the Clinical Oncology Workflow: Data Challenges, Proposed Solutions, and a Call to Action by Conway, Jake R., Warner, Jeremy L., Rubinstein, Wendy S., Miller, Robert S.

Get full text Get full text Get full text

Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine by Conway, Jake R., Kofman, Eric, Mo, Shirley S., Elmarakeby, Haitham, Van Allen, Eliezer

Get full text Get full text Get full text

Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy by Mossanen, Matthew, Carvalho, Filipe L.F., Muralidhar, Vinayak, Preston, Mark, Reardon, Brendan, Conway, Jake R., Curran, Catherine, Freeman, Dory, Sha, Sybil, Sonpavde, Guru, Hirsch, Michelle, Kibel, Adam S., Van Allen, Eliezer M., Mouw, Kent W.

Get full text Get full text Get full text

Integrated molecular drivers coordinate biological and clinical states in melanoma by Conway, Jake R., Dietlein, Felix, Taylor-Weiner, Amaro, AlDubayan, Saud, Vokes, Natalie, Keenan, Tanya, Reardon, Brendan, He, Meng Xiao, Margolis, Claire A., Weirather, Jason L., Haq, Rizwan, Schilling, Bastian, Hodi, F. Stephen, Schadendorf, Dirk, Liu, David, Van Allen, Eliezer M.

Get full text Get full text Get full text

LSD1 ablation stimulates anti-tumor immunity and enables checkpoint blockade by Sheng, Wanqiang, LaFleur, Martin W., Nguyen, Thao H., Chen, Sujun, Chakravarthy, Ankur, Conway, Jake Ryan, Li, Ying, Chen, Hao, Yang, Henry, Hsu, Pang-Hung, Van Allen, Eliezer M., Freeman, Gordon J., De Carvalho, Daniel D., He, Housheng Hansen, Sharpe, Arlene H., Shi, Yang

Get full text Get full text Get full text

Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma by AlDubayan, Saud H., Conway, Jake R., Camp, Sabrina Y., Witkowski, Leora, Kofman, Eric, Reardon, Brendan, Han, Seunghun, Moore, Nicholas, Elmarakeby, Haitham, Salari, Keyan, Choudhry, Hani, Al-Rubaish, Abdullah M., Al-Sulaiman, Abdulsalam A., Al-Ali, Amein K., Taylor-Weiner, Amaro, Van Allen, Eliezer M.

Get full text Get full text Get full text

Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology by Reardon, Brendan, Moore, Nathanael D, Moore, Nicholas S, Kofman, Eric, AlDubayan, Saud H, Cheung, Alexander TM, Conway, Jake, Elmarakeby, Haitham, Imamovic, Alma, Kamran, Sophia C, Keenan, Tanya, Keliher, Daniel, Konieczkowski, David J, Liu, David, Mouw, Kent W, Park, Jihye, Vokes, Natalie I, Dietlein, Felix, Van Allen, Eliezer M

Get full text Get full text Get full text

Clinical efficacy and molecular response correlates of the WEE1 inhibitor adavosertib combined with cisplatin in patients with metastatic triple-negative breast cancer (mTNBC) by Keenan, Tanya E., Li, Tianyu, Vallius, Tuulia, Guerriero, Jennifer L., Tayob, Nabihah, Kochupurakkal, Bose, Davis, Janae, Pastorello, Ricardo, Tahara, Rie K., Anderson, Leilani, Conway, Jake, He, Meng X., Shannon, Erin, Godin, Robert E., Sorger, Peter K., D’Andrea, Alan, Overmoyer, Beth, Winer, Eric P., Mittendorf, Elizabeth A., Van Allen, Eliezer M., Shapiro, Geoffrey I., Tolaney, Sara M.

Get full text Get full text Get full text

Gene Fusions Create Partner and Collateral Dependencies Essential to Cancer Cell Survival by Gillani, Riaz, Seong, Bo Kyung A., Crowdis, Jett, Conway, Jake R., Dharia, Neekesh V., Alimohamed, Saif, Haas, Brian J., Han, Kyuho, Park, Jihye, Dietlein, Felix, He, Meng Xiao, Imamovic, Alma, Ma, Clement, Bassik, Michael C., Boehm, Jesse S., Vazquez, Francisca, Gusev, Alexander, Liu, David, Janeway, Katherine A., McFarland, James M., Stegmaier, Kimberly, Van Allen, Eliezer M.

Get full text Get full text Get full text

Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer by Keenan, Tanya E., Guerriero, Jennifer L., Barroso-Sousa, Romualdo, Li, Tianyu, O’Meara, Tess, Giobbie-Hurder, Anita, Tayob, Nabihah, Hu, Jiani, Severgnini, Mariano, Agudo, Judith, Vaz-Luis, Ines, Anderson, Leilani, Attaya, Victoria, Park, Jihye, Conway, Jake, He, Meng Xiao, Reardon, Brendan, Shannon, Erin, Wulf, Gerburg, Spring, Laura M., Jeselsohn, Rinath, Krop, Ian, Lin, Nancy U., Partridge, Ann, Winer, Eric P., Mittendorf, Elizabeth A., Liu, David, Van Allen, Eliezer M., Tolaney, Sara M.

Get full text Get full text Get full text

Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade by Gu, Shengqing Stan, Zhang, Wubing, Wang, Xiaoqing, Jiang, Peng, Traugh, Nicole, Li, Ziyi, Meyer, Clifford, Stewig, Blair, Xie, Yingtian, Bu, Xia, Manos, Michael P., Font-Tello, Alba, Gjini, Evisa, Lako, Ana, Lim, Klothilda, Conway, Jake, Tewari, Alok K., Zeng, Zexian, Sahu, Avinash Das, Tokheim, Collin, Weirather, Jason L., Fu, Jingxin, Zhang, Yi, Kroger, Benjamin, Liang, Jin Hua, Cejas, Paloma, Freeman, Gordon J., Rodig, Scott, Long, Henry W., Gewurz, Benjamin E., Hodi, F. Stephen, Brown, Myles, Liu, X. Shirley

Get full text Get full text Get full text

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma by Liu, David, Schilling, Bastian, Liu, Derek, Sucker, Antje, Livingstone, Elisabeth, Jerby-Arnon, Livnat, Zimmer, Lisa, Gutzmer, Ralf, Satzger, Imke, Loquai, Carmen, Grabbe, Stephan, Vokes, Natalie, Margolis, Claire A., Conway, Jake, He, Meng Xiao, Elmarakeby, Haitham, Dietlein, Felix, Miao, Diana, Tracy, Adam, Gogas, Helen, Goldinger, Simone M., Utikal, Jochen, Blank, Christian U., Rauschenberg, Ricarda, von Bubnoff, Dagmar, Krackhardt, Angela, Weide, Benjamin, Haferkamp, Sebastian, Kiecker, Felix, Izar, Ben, Garraway, Levi, Regev, Aviv, Flaherty, Keith, Paschen, Annette, Van Allen, Eliezer M., Schadendorf, Dirk

Get full text Get full text Get full text

Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma by Liu, David, Schilling, Bastian, Liu, Derek, Sucker, Antje, Livingstone, Elisabeth, Jerby-Arnon, Livnat, Zimmer, Lisa, Gutzmer, Ralf, Satzger, Imke, Loquai, Carmen, Grabbe, Stephan, Vokes, Natalie, Margolis, Claire A., Conway, Jake, He, Meng Xiao, Elmarakeby, Haitham, Dietlein, Felix, Miao, Diana, Tracy, Adam, Gogas, Helen, Goldinger, Simone M., Utikal, Jochen, Blank, Christian U., Rauschenberg, Ricarda, von Bubnoff, Dagmar, Krackhardt, Angela, Weide, Benjamin, Haferkamp, Sebastian, Kiecker, Felix, Izar, Ben, Garraway, Levi, Regev, Aviv, Flaherty, Keith, Paschen, Annette, Van Allen, Eliezer M., Schadendorf, Dirk

Get full text Get full text Get full text